Bo Albinsson

Corrigendum to “The effect of the TBE vaccination program in the Åland Islands” [Vaccine: X 27 (2025) 100727]

Tove Hoffman, Bo Albinsson, Linda Kolstad, Marika Nordberg et autres

se, ax, fi (code pays fourni par la source)

The effect of the TBE vaccination program in the Åland Islands

Tove Hoffman, Bo Albinsson, Linda Kolstad, Marika Nordberg et autres

The Åland Islands included tick-borne encephalitis (TBE) vaccination in the general vaccination program in 2006. Investigate the effect of the vaccination on the number of reported TBE cases and the TBEV IgG seroprevalence in blood donors in the Åland Islands. We used …

se, ax, fi (code pays fourni par la source)

Adverse drug reactions following SARS-CoV-2 vaccination of 3805 healthcare workers cause substantial sick-leave and are correlated to vaccine regimen, age, sex and serological response

Anna-Karin Lidström, Bo Albinsson, Fredrik Sund, Johan Lindbäck et autres

BACKGROUND: Although SARS-CoV-2 vaccination was a critical component to mitigate impact of the pandemic, it also brought specific challenges related to adverse drug reactions (ADRs) when large cohorts of healthcare workers were vaccinated. METHODS AND FINDINGS: This study reports solicited ADRs and …

se, nl (code pays fourni par la source)

Seroprevalence of tick-borne encephalitis virus and vaccination coverage of tick-borne encephalitis, Sweden, 2018 to 2019

Bo Albinsson, Tove Hoffman, Linda Kolstad, Tomas B. Bergström et autres

BackgroundIn Sweden, information on seroprevalence of tick-borne encephalitis virus (TBEV) in the population, including vaccination coverage and infection, is scattered. This is largely due to the absence of a national tick-borne encephalitis (TBE) vaccination registry, scarcity of previous serological studies and use …

se (code pays fourni par la source)

A third dose SARS‑CoV‑2 BNT162b2 mRNA vaccine results in improved immune response in hemodialysis patients

Jan Melin, Maria K Eriksson Svensson, Bo Albinsson, Ola Winqvist et autres

Background: The hemodialysis (HD) population has been a vulnerable group during the coronavirus disease 2019 (COVID-19) pandemic. Advanced chronic kidney disease with uremia is associated with weaker immune response to infections and an attenuated response to vaccines. The aim of this study …

se (code pays fourni par la source)

MO169: Three Doses of SARS‑COV‑2 BNT162B2 MRNA Vaccine Results in an Enhanced Immunologic B- And T-Cell Response in Haemodialysis Patients

Jan Melin, Maria K Eriksson Svensson, Bo Albinsson, Ola Winqvist et autres

Abstract BACKGROUND AND AIMS The immune system is affected by uremia. Haemodialysis (HD) patients have an increased risk of acquiring infections due to many healthcare contacts and have a suboptimal response to vaccination and a high mortality from COVID-19 infection. Accumulating data …

se (code pays fourni par la source)

Humoral and cellular response to SARS-CoV-2 BNT162b2 mRNA vaccine in hemodialysis patients

Jan Melin, Maria K Eriksson Svensson, Bo Albinsson, Ola Winqvist et autres

BACKGROUND: Hemodialysis (HD) patients have an increased risk of acquiring infections due to many health care contacts and may, in addition, have a suboptimal response to vaccination and a high mortality from Covid-19 infection. METHODS: In 50 HD patients (mean age 69.4 …

se (code pays fourni par la source)

Antibody and T Cell Reactivity Response After SARS-CoV-2 BNT162b2 mRNA Vaccine in Hemodialysis Patients: A Single-Center Experience from Sweden

Jan Melin, Maria K Eriksson Svensson, Bo Albinsson, Karlis Pauksens

Background: The immune system is affected by uremia. Patients with end-stage kidney disease (ESKD) on hemodialysis treatment (HD) are vulnerable to infections, may have suboptimal response to vaccination and are at increased risk of contagious infections due to many health care contacts. …

se (code pays fourni par la source)

Diagnostic Potential of a Luminex-Based Coronavirus Disease 2019 Suspension Immunoassay (COVID-19 SIA) for the Detection of Antibodies against SARS-CoV-2

Tove Hoffman, Linda Kolstad, Johanna Frida Lindahl, Bo Albinsson et autres

Due to the current, rapidly increasing Coronavirus disease 2019 (COVID-19) pandemic, efficient and highly specific diagnostic methods are needed. The receptor-binding part of the spike (S) protein, S1, has been suggested to be highly virus-specific; it does not cross-react with antibodies against …

se (code pays fourni par la source)

Antibody Responses to Severe Acute Respiratory Syndrome Coronavirus 2 in the Serum and Cerebrospinal Fluid of Patients With Coronavirus Disease 2019 and Neurological Symptoms

Janet L. Cunningham, Johan Virhammar, Bengt J. Rönnberg, Xaquín Castro Dopico et autres

Antibody responses to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in serum and cerebrospinal fluid (CSF) samples from 16 patients with coronavirus disease 2019 and neurological symptoms were assessed using 2 independent methods. Immunoglobulin G (IgG) specific for the virus spike protein …

se, gb (code pays fourni par la source)

Work at inpatient care units is associated with an increased risk of SARS-CoV-2 infection; a cross-sectional study of 8679 healthcare workers in Sweden

Anna-Karin Lidström, Fredrik Sund, Bo Albinsson, Johan Lindbäck et autres

BACKGROUND: During the Covid-19 pandemic, the protection of healthcare workers has been in focus throughout the world, but the availability and quality of personal protective equipment has at times and in some settings been suboptimal. MATERIALS AND METHODS: A total of 8679 …

se (code pays fourni par la source)

Multi-laboratory evaluation of ReaScan TBE IgM rapid test, 2016 to 2017

Bo Albinsson, Anu Jääskeläinen, Kairi Värv, Mateja Jelovšek et autres

Background Tick-borne encephalitis (TBE) is a potentially severe neurological disease caused by TBE virus (TBEV). In Europe and Asia, TBEV infection has become a growing public health concern and requires fast and specific detection. Aim In this observational study, we evaluated a …

se, fi, ee, si, nl (code pays fourni par la source)